GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
166 hedge funds and large institutions have $1.63B invested in Genomic Health, Inc. in 2018 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+32
Holders Change %
+23.88%
% of All Funds
3.81%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
42
Increased
52
Reduced
50
Closed
10
Calls
$1.77M
Puts
$912K
Net Calls
+$861K
Net Calls Change
-$3.28M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$72.9M |
| 2 |
2
Renaissance Technologies
New York
|
$70.8M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$12.4M |
| 4 |
4
Goldman Sachs
New York
|
$31M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$91.4M |
